OFI Invest Asset Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$694K Buy
3,755
+2,570
+217% +$533K 0.01% 299
2026
Q1
$231K Buy
1,185
+422
+55% +$105K ﹤0.01% 330
2025
Q4
$156K Buy
763
+254
+50% +$65K ﹤0.01% 349
2025
Q3
$119K Buy
509
+48
+10% +$13.1K ﹤0.01% 237
2025
Q2
$101K Buy
461
+150
+48% +$35.8K ﹤0.01% 226
2025
Q1
$64.4K Buy
311
+136
+78% +$31.8K ﹤0.01% 302
2024
Q4
$38.6K Buy
+175
New +$42.1K ﹤0.01% 326
2024
Q2
$32K Buy
+179
New +$36.3K ﹤0.01% 316

Other funds holding RMD

OFI Invest Asset Management's RMD Position: Q2 2026 in Review

OFI Invest Asset Management increased its ResMed (RMD) stake by 217% in Q2 2026, buying an estimated $533K and bringing the position to 3,755 shares worth $694K. The position accounts for 0.01% of the portfolio, ranked #299.

OFI Invest Asset Management first reported a position in RMD in Q2 2024 and has held it in 8 quarters since. 179 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • OFI Invest Asset Management held 3,755 shares of ResMed worth $694K as of Q2 2026.
  • OFI Invest Asset Management bought 2,570 ResMed shares in Q2 2026, an estimated $533K.
  • ResMed made up 0.01% of OFI Invest Asset Management's portfolio in Q2 2026, its #299 holding.
  • OFI Invest Asset Management first reported a position in ResMed in Q2 2024 and has held it in 8 quarters since.
  • 179 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on OFI Invest Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.